Association between the expression of MUC1 and MUC3 in cancer tissues and the clinicopathological features of the patient
| Variables | n | MUC1 (+) | n | MUC3 (+) |
|---|---|---|---|---|
| NS, not significant. | ||||
| Sex | ||||
| Male | 34 | 23 (67.6%) | 34 | 23 (67.6%) |
| Female | 12 | 6 (50.0%) | 11 | 7 (63.6%) |
| p Value | NS | NS | ||
| Tumour location | ||||
| Fundus | 7 | 6 (85.7%) | 7 | 3 (42.9%) |
| Body | 13 | 6 (46.2%) | 13 | 9 (69.2%) |
| Antrum | 26 | 17 (65.4%) | 25 | 18 (72.0%) |
| p Value | NS | NS | ||
| Size | ||||
| ≤5 cm | 31 | 24 (77.4%) | 31 | 21 (67.7%) |
| >5 cm | 15 | 5 (33.3%) | 14 | 9 (64.3%) |
| p Value | <0.01 | NS | ||
| Differentiation | ||||
| Well/moderate | 26 | 17 (65.4%) | 26 | 20 (76.9%) |
| Poor | 17 | 10 (58.8%) | 16 | 8 (50.0%) |
| Mucoid | 3 | 2 (66.7%) | 3 | 2 (66.7%) |
| p Value | NS | NS | ||
| Metastasis | ||||
| Present | 23 | 11 (47.8%) | 23 | 20 (87.0%) |
| Absent | 23 | 18 (78.3%) | 22 | 10 (45.5%) |
| p Value | <0.05 | <0.01 | ||
| Serosal invasion | ||||
| Present | 26 | 16 (61.5%) | 25 | 20 (80.0%) |
| Absent | 20 | 13 (65.0%) | 20 | 10 (50.0%) |
| p Value | NS | <0.05 | ||
| Clinical stage | ||||
| I–II | 26 | 21 (80.8%) | 25 | 12 (48.0%) |
| III–IV | 20 | 8 (40.0%) | 20 | 18 (90.0%) |
| p Value | <0.01 | <0.05 | ||
| Types of carcinoma | ||||
| Intestinal | 21 | 13 (61.9%) | 20 | 12 (60.0%) |
| Diffuse | 17 | 11 (64.7%) | 17 | 11 (64.7%) |
| Mixed | 8 | 5 (62.5%) | 8 | 7 (87.5%) |
| p Value | NS | NS | ||